WHAT TO EXPECT FROM A PHENYTOIN DRUG-DRUG INTERACTION STUDY: ADVERSE EVENT PROFILING AND SAFETY ASSESSMENT

被引：0
|
作者：
Paglialunga, S. [1 ]
van Haarst, A. [2 ]
机构：
[1] Celerion, Tempe, AZ USA
[2] Celerion, Belfast, Antrim, North Ireland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-032
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Leucovorin-phenytoin: A drug-drug interaction? Comment
    Tidwell, BH
    Cleary, JD
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) : 1303 - 1304
  • [2] PHENYTOIN-DEXAMETHASONE - A POSSIBLE DRUG-DRUG INTERACTION
    WONG, DD
    LONGENECKER, RG
    LIEPMAN, M
    BAKER, S
    LAVERGNE, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (15): : 2062 - 2063
  • [3] Assessment of drug-drug interaction for silymarin
    Doehmer, Johannes
    Tewes, Bernhard
    Klein, Kai-Uwe
    Gritzko, Kristin
    Muschick, Holger
    Mengs, Ulrich
    TOXICOLOGY IN VITRO, 2008, 22 (03) : 610 - 617
  • [4] DRUG-DRUG INTERACTION PREDICTION ASSESSMENT
    Zhou, Jihao
    Qin, Zhaohui
    Sara, Quinney K.
    Kim, Seongho
    Wang, Zhiping
    Hall, Stephen D.
    Li, Lang
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (04) : 641 - 657
  • [5] Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects
    Spaans, E
    van den Heuvel, MW
    Schnabel, PG
    Peeters, PAM
    Chin-Kon-Sung, UG
    Colbers, EPH
    Sitsen, JMA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) : 423 - 429
  • [6] CLINICAL EFFECT OF THE POTENTIAL DRUG-DRUG INTERACTION BETWEEN PHENYTOIN AND PHENOBARBITAL
    Landolf, Kaitlin
    Malinowski, Ashleigh
    Durkin, Joseph
    CRITICAL CARE MEDICINE, 2020, 48
  • [7] ROLE OF HYDROXYLATED METABOLITES OF PHENYTOIN IN DOSE DEPENDENCY AND DRUG-DRUG INTERACTION
    GLAZKO, AJ
    BORONDY, P
    CHANG, T
    YOUNG, R
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1976, 357 (08): : 1028 - 1028
  • [8] Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (01) : 45 - 48
  • [9] What is the true risk of a pharmacokinetic drug-drug interaction?
    Fuhr, Uwe
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (10) : 897 - 899
  • [10] Power Calculation for Drug-Drug Interaction in Safety Studies
    Cai, Bing
    Zhou, Xiaofeng
    Bate, Andrew J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S309 - S310
12345